e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Diagnosis and treatment of drug susceptible and resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dynamics of morphological changes at multi drug resistant experimental lung tuberculosis
M. Dziusmikeyeva, L. Surkova (Minsk, Belarus)
Source:
Annual Congress 2007 - Diagnosis and treatment of drug susceptible and resistant tuberculosis
Session:
Diagnosis and treatment of drug susceptible and resistant tuberculosis
Session type:
Thematic Poster Session
Number:
3861
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Dziusmikeyeva, L. Surkova (Minsk, Belarus). Dynamics of morphological changes at multi drug resistant experimental lung tuberculosis. Eur Respir J 2007; 30: Suppl. 51, 3861
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Related content which might interest you:
Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Estimation of reparative processes intensity at MDR lung tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia
Source: Virtual Congress 2020 – Tuberculosis and comorbidities
Year: 2020
Morphological changes of a small intestine wall in patients with multidrug resistant tuberculosis
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021
The peculiarities of course and treatment of pulmonary tuberculosis with initial drug resistance
Source: Eur Respir J 2003; 22: Suppl. 45, 41s
Year: 2003
Assessment of the dynamics of focal changes after the intensive phase of treatment in patients with sensitive and resistant pulmonary tuberculosis
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
The clinical features and treatment results of cases with multidrug resistant pulmonary tuberculosis
Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis
Year: 2004
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Relationship between exposure with drug resistant tuberculosis and developing new resistant cases
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Treatment of multidrug resistant pulmonary tuberculosis (MDR-TB) with different pattern of resistance
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004
Clinical characteristic of the patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 661s
Year: 2007
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Defining optimal fluoroquinolone exposure against
Mycobacterium tuberculosis
: contribution of murine studies
Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020
Year: 2021
Lipid profile in patients with multidrug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 361s
Year: 2002
Multi drug resistent lung tuberculosis: Our results of surgical treatment
Source: Annual Congress 2010 - Infections and pleural problems
Year: 2010
Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre
Source: Eur Respir J 2003; 22: Suppl. 45, 524s
Year: 2003
The effects of drug resistance phenotype on proliferation of
Mycobacterium tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004
Association of genetic markers with clinical course of patients with pulmonary tuberculosis with drug resistance
Source: Eur Respir J 2007; 30: Suppl. 51, 203s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept